Cargando…

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population

Colorectal cancer (CRC) is the third leading cause of cancer death in the US. Early detection improves CRC outcomes and multiple options are endorsed for CRC screening; however, adherence remains challenging. Among Medicaid enrollees, the fecal immunochemical test (FIT) is often used for average-ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller-Wilson, Lesley-Ann, Finney Rutten, Lila J., Van Thomme, Jack, Burak Ozbay, A., Laffin, Jennifer, Limburg, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747618/ https://www.ncbi.nlm.nih.gov/pubmed/36531112 http://dx.doi.org/10.1016/j.pmedr.2022.102032

Ejemplares similares

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Provider-perceived barriers to patient adherence to colorectal cancer screening
por: Zhu, Xuan, et al.
Publicado: (2021)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults
por: Weiser, Emily, et al.
Publicado: (2020)

Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
por: Mark Fendrick, A., et al.
Publicado: (2022)

Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids
por: Ebner, Derek W., et al.
Publicado: (2023)

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model
por: Piscitello, Andrew, et al.
Publicado: (2020)

Initial validation of a self-report questionnaire based on the Theoretical Domains Framework: determinants of clinician adoption of a novel colorectal cancer screening strategy
por: Zhu, Xuan, et al.
Publicado: (2021)

Comparison of Simulated Outcomes Between Stool- and Blood-Based Colorectal Cancer Screening Tests
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Evaluation of a multimedia outreach campaign for a multi-target stool DNA test for colorectal cancer screening among non-medicare employer population in the United States
por: Shepherd, Martha E., et al.
Publicado: (2022)

Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)
por: Olson, Janet E, et al.
Publicado: (2020)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA
por: Ebner, Derek W., et al.
Publicado: (2021)

The impact of multi-target stool DNA testing in clinical practice in the United States: A real-world evidence retrospective study
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Factors influencing colorectal cancer screening decision-making among average-risk US adults
por: Zhu, Xuan, et al.
Publicado: (2022)

Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population
por: Shepherd, Martha E., et al.
Publicado: (2021)

Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment
por: Heidenreich, Sebastian, et al.
Publicado: (2022)

Barriers to utilization of three colorectal cancer screening options – Data from a national survey
por: Zhu, Xuan, et al.
Publicado: (2021)

An examination of socioeconomic and racial/ethnic disparities in the awareness, knowledge and utilization of three colorectal cancer screening modalities
por: Zhu, Xuan, et al.
Publicado: (2021)

Healthcare Provider Perspectives on Lowering Colorectal Cancer Screening Initiation Age to 45 Years: Results From a Survey of Clinicians in the U.S.
por: Rutten, Lila J. Finney, et al.
Publicado: (2020)

Factors Associated With Clinician Recommendations for Colorectal Cancer Screening Among Average-Risk Patients: Data From a National Survey
por: Zhu, Xuan, et al.
Publicado: (2022)

Colorectal cancer screening completion: An examination of differences by screening modality
por: Finney Rutten, Lila J., et al.
Publicado: (2020)

Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
por: Imperiale, Thomas F., et al.
Publicado: (2023)

Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy
por: Eckmann, Jason D., et al.
Publicado: (2020)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk
por: Fisher, Deborah A., et al.
Publicado: (2021)

Colorectal screening among average risk individuals in the United States, 2015–2018
por: Engel-Nitz, Nicole M., et al.
Publicado: (2022)

Patient and provider factors associated with colorectal cancer screening among average risk health plan enrollees in the US, 2015–2018
por: Engel-Nitz, Nicole M., et al.
Publicado: (2023)

Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study
por: Itzkowitz, Steven, et al.
Publicado: (2023)

The COMPASS study: A prospective, randomized, multi-center trial testing the impact of a clinic-based intervention informing patients of colorectal cancer screening options on screening completion
por: Griffin, Joan M., et al.
Publicado: (2022)

Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020
por: Mohl, Jeff T., et al.
Publicado: (2023)

Barriers and facilitators of colorectal cancer screening using the 5As framework: A systematic review of US studies
por: Agunwamba, Amenah A., et al.
Publicado: (2023)

Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model
por: Fisher, Deborah A., et al.
Publicado: (2020)

The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population
por: Hathway, Joanne M, et al.
Publicado: (2021)

Inappropriate Multi-Target Stool DNA Use for Colorectal Cancer Screening: Risks, Compliance, and Outcomes
por: Lazar, Nicholas J, et al.
Publicado: (2023)

Patient perceptions of electronic medical records use and ratings of care quality
por: Finney Rutten, Lila J, et al.
Publicado: (2014)

Attitudes and Experiential Factors Associated with Completion of mt-sDNA Test Kit for Colorectal Cancer Screening
por: Finney Rutten, Lila J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fl9t7qkrjqr83n6o0206abq59p